Search Within

Noura Jehan Choudhury

Formats
  1. Meeting Abstract (18)
  2. Journal Article (17)
  3. Editorial (2)
  4. Review (2)
  5. Correspondence (1)
Groups
  1. GME, Medicine (40)
  2. Graduate Medical Education (40)
  3. Hematology-Oncology Fellows (40)
  4. Weinberg Fellows (40)
  5. Department of Medicine (31)
  6. Solid Tumor Oncology Division (31)

More Groups

People
  1. Alexander Drilon (15)
  2. Christina Falcon (12)
  3. Soo Ryum Yang (10)
  4. Gregory Riely (9)
  5. Charles Rudin (8)
  6. Glenn Heller (7)

More People

Years
  1. 2025 (2)
  2. 2024 (12)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (6)
  6. 2020 (4)
Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (6)
  3. JCO Precision Oncology (4)
  4. Journal of Thoracic Oncology (4)
  5. Annals of Oncology (2)
  6. JTO Clinical and Research Reports (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. American Association for Cancer Research (7)
  3. Elsevier Inc. (5)
  4. Oxford University Press (3)
  5. Elsevier BV (2)
  6. American Medical Association (1)

More Publishers

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers
    Journal Article

    Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C. J.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
    JTO Clinical and Research Reports (2021)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers
    Meeting Abstract

    Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Meeting Abstract

    Hubbeling, H. G.; Choudhury, N.; Falcon, C.; Rusch, V. W.; Park, B.; Ziv, E.; Shaverdian, N.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research
    Correspondence

    Choudhury, N. J.; Riely, G. J.; Sabbatini, P. J.; Hellmann, M. D.
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
    Journal Article

    Choudhury, N. J.; Schoenfeld, A. J.; Flynn, J.; Falcon, C. J.; Rizvi, H.; Rudin, C. M.; Kris, M. G.; Arcila, M. E.; Heller, G.; Yu, H. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Spectrum of mechanisms of resistance to crizotinib and lorlatinib in ROS1 fusion–positive lung cancer
    Journal Article

    Lin, J. J.; Choudhury, N. J.; Yoda, S.; Zhu, V. W.; Johnson, T. W.; Sakhtemani, R.; Dagogo-Jack, I.; Digumarthy, S. R.; Lee, C.; Do, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic characterization of a RET inhibitor–resistant RET fusion–positive lung cancer by CSF cell-free DNA hybrid capture–based sequencing
    Journal Article

    Choudhury, N. J.; Yang, S. R.; Arcila, M.; Mohanty, A. S.; Boire, A.; Drilon, A.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Decade in review: A new era for RET-rearranged lung cancers
    Review

    Choudhury, N. J.; Drilon, A.
    Translational Lung Cancer Research (2020)

    Fulltext@MSK | Save
  • Lorlatinib and bevacizumab activity in ALK-rearranged lung cancers after lorlatinib progression
    Journal Article

    Choudhury, N. J.; Young, R. J.; Sellitti, M.; Miller, A.; Drilon, A.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Training oncologists in the time of COVID-19
    Editorial

    Choudhury, N.; Shoushtari, A.
    The Oncologist (2020)

    Fulltext@MSK | Save